z-logo
open-access-imgOpen Access
Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
Author(s) -
Charlene M. Prazma,
Marco Idzko,
Jo A Douglass,
Arnaud Bourdin,
Stephen Mallett,
Frank Albers,
Steven W. Yancey
Publication year - 2021
Publication title -
journal of asthma and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.162
H-Index - 30
ISSN - 1178-6965
DOI - 10.2147/jaa.s298559
Subject(s) - medicine , atopy , mepolizumab , asthma , placebo , eosinophil , atopic dermatitis , eosinophil cationic protein , immunology , immunoglobulin e , gastroenterology , antibody , pathology , alternative medicine
Improved understanding of characteristics that may influence treatment response across phenotypes may help guide treatment decisions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here